Benzinga | Nov 5, 2020 05:04PM EST

Cidara Therapeutics Q3 EPS $(0.41) Down From $0.08 YoY, Sales $2.40M Down From $19.10M YoY

Cidara Therapeutics (NASDAQ:CDTX) reported quarterly losses of $(0.41) per share. This is a 612.5 percent decrease over earnings of $0.08 per share from the same period last year. The company reported $2.40 million in sales this quarter. This is a 87.43 percent decrease over sales of $19.10 million the same period last year.